PARVA plays multifaceted roles in cellular processes:
Cell Adhesion and Motility: Integrates with integrin-linked kinase (ILK) and PINCH to form focal adhesion complexes, bridging extracellular matrix signals to actin cytoskeleton reorganization .
Cancer Progression:
Cardiovascular Development: Essential for embryonic heart septation and vascular smooth muscle adhesion .
Key studies highlight PARVA's oncogenic role:
Condition | Effects | Mechanism |
---|---|---|
Overexpression | ↑ Invasion, colony formation, metastasis | ILK phosphorylation → Akt/GSK3β activation |
Knockdown | ↓ Tumorigenesis, tube formation | ILK pathway suppression |
Pathway | Role in Cancer | Key Molecules |
---|---|---|
ILK Signaling | Enhances cell survival, invasion, and angiogenesis | ILK, Akt, GSK3β |
Cytoskeletal Remodeling | Facilitates metastasis via actin dynamics | Actin, Paxillin |
Recombinant PARVA is widely used in:
Mechanistic Studies: Investigating ILK-dependent signaling in cancer .
In Vitro Assays**: Migration, adhesion, and angiogenesis models .
Product Comparison | Prospec Bio (PRO-1257) | Boster Bio (PROTQ9NVD7) |
---|---|---|
Host | E. coli | HEK293T cells |
Tag | His-tag | C-Myc/DDK |
Concentration | 0.5 mg/mL | >50 µg/mL |
The PARVA gene encodes the protein alpha-parvin in humans. Alpha-parvin is a critical component in multiple cellular processes, functioning primarily as a structural and signaling protein within the cell architecture. The protein participates in focal adhesion complexes and contributes to cytoskeletal organization that underpins cellular morphology and movement . Research approaches to understand PARVA gene expression typically include RT-PCR, Northern blotting, and RNA-seq methodologies that quantify transcription levels across different tissue types and experimental conditions.
Alpha-parvin participates in numerous fundamental cellular processes that include:
Sarcomere organization in muscle cells
Smooth muscle cell contraction regulation
Reorganization of the actin cytoskeleton
Formation of lamellipodia during cell movement
Ciliogenesis in appropriate cell types
Establishment of cell polarity
Mediation of cell adhesion processes
Facilitation of cell spreading behaviors
Investigating these functions requires multiple experimental approaches including immunofluorescence microscopy, live cell imaging, and various biochemical assays that track protein-protein interactions and cytoskeletal dynamics.
Alpha-parvin plays essential roles in cardiovascular development through several mechanisms. The protein is required for normal development of the embryonic cardiovascular system and correct septation of the heart outflow tract. Additionally, it facilitates sprouting angiogenesis and mediates the normal adhesion of vascular smooth muscle cells to endothelial cells during blood vessel formation and maturation .
Research methodologies to study these developmental roles typically involve:
Embryonic tissue sectioning and immunohistochemistry
Developmental timing analyses using controlled expression systems
Cardiovascular-specific knockout models
Ex vivo vessel formation assays
Endothelial-smooth muscle co-culture systems
Researchers can access various experimental tools for studying alpha-parvin across different mammalian species:
Species | Available Research Tools | Applications |
---|---|---|
Human (Homo sapiens) | Multiple antibodies (HRP/FITC/Biotin conjugated), Recombinant proteins from various expression systems | ELISA, Western Blot, Immunohistochemistry, Immunofluorescence |
Mouse (Mus musculus) | Antibodies with cross-reactivity, Recombinant proteins | ELISA, Western Blot, Immunohistochemistry |
Rat (Rattus norvegicus) | Antibodies with cross-reactivity, Recombinant proteins | ELISA, Western Blot, Immunohistochemistry |
This cross-species availability facilitates comparative studies and translation between model organisms and human systems.
Alpha-parvin's interaction with the actin cytoskeleton represents a critical aspect of its function in cell motility and morphology. To effectively investigate these interactions, researchers should implement:
Co-immunoprecipitation assays to identify direct binding partners
Proximity ligation assays to visualize protein-protein interactions in situ
FRET/FLIM microscopy to quantify dynamic interactions in living cells
Purified protein binding assays with actin filaments
Super-resolution microscopy (STORM, PALM) to visualize nanoscale organization
Actin treadmilling assays to assess effects on cytoskeletal dynamics
The combination of these approaches provides complementary data on both static and dynamic aspects of PARVA-actin interactions, offering insights into mechanical and signaling functions.
Establishing causality in PARVA's role in cell polarity requires sophisticated experimental designs:
Rescue experiments using structure-function mutants of PARVA
Acute protein inactivation using optogenetic or chemical genetic approaches
Domain-specific disruption of protein interactions
Temporal analysis using synchronized cell systems
Quantitative assessment of polarity markers with simultaneous PARVA visualization
Mathematical modeling of polarity formation with and without PARVA function
These approaches help delineate the direct mechanistic contributions of PARVA to polarity establishment versus secondary effects resulting from altered cytoskeletal organization or adhesion dynamics.
Investigating PARVA in angiogenesis presents specific methodological challenges:
Achieving endothelial-specific manipulation without affecting supporting cells
Distinguishing cell-autonomous effects from paracrine signaling
Visualizing real-time protein dynamics during sprouting events
Recapitulating the complex extracellular matrix environment in vitro
Quantifying subtle phenotypic changes in vessel morphology and function
Separating PARVA's roles in tip versus stalk cells during sprouting
Researchers can address these challenges through microfluidic angiogenesis models, endothelial-specific inducible genetic systems, advanced intravital imaging, and computational analysis of sprouting dynamics.
Studying the temporal aspects of PARVA function in cardiovascular development requires specialized techniques:
Time-controlled genetic deletion systems (inducible Cre-lox)
In utero manipulation of gene expression at specific developmental stages
Live imaging of embryonic cardiovascular structures
Stage-specific transcriptomic and proteomic profiling
4D analysis of protein localization during heart development
Correlation of PARVA expression patterns with developmental milestones
These approaches help establish critical windows when PARVA function is essential and identify stage-specific interaction partners that may modulate its activity.
Current research shows both stimulatory and inhibitory roles for PARVA in lamellipodia formation, suggesting context-dependent functions. Methodological approaches to resolve these contradictions include:
Cell-type specific analysis of lamellipodia dynamics
Quantitative parameter measurement of lamellipodia properties (persistence, area, rate of formation)
Systematic testing across extracellular matrix composition conditions
Integration of mechanical stimulation with biochemical analysis
Single-cell analysis to account for heterogeneity within populations
Correlation with activity states of upstream regulators and downstream effectors
These systematic approaches can help identify specific conditions under which PARVA promotes versus inhibits lamellipodia formation.
Several validated antibodies are available for detecting human PARVA in research applications:
Antibody Code | Specificity | Conjugation | Applications | Species Reactivity |
---|---|---|---|---|
CSB-PA017474GA01HU | PARVA | Unconjugated | ELISA, WB, IHC | Human, Mouse, Rat |
CSB-PA868328LA01HU | PARVA | Unconjugated | ELISA, WB, IHC, IF | Human, Rat |
CSB-PA868328LB01HU | PARVA | HRP | ELISA | Human |
CSB-PA868328LC01HU | PARVA | FITC | Not specified | Human |
CSB-PA868328LD01HU | PARVA | Biotin | ELISA | Human |
When selecting antibodies, researchers should consider validation status, application compatibility, and cross-reactivity with other species if comparative studies are planned. Verification through multiple antibodies is recommended for confirming specificity of signals.
Researchers have multiple options for recombinant PARVA protein production:
Expression System | Product Code | Advantages | Typical Applications |
---|---|---|---|
Yeast | CSB-YP868328HU | Eukaryotic processing, High yield | Structural studies, Antibody production |
E. coli | CSB-EP868328HU | Cost-effective, Scalable | Binding assays, Biochemical characterization |
Baculovirus | CSB-BP868328HU | Post-translational modifications | Functional assays, Enzymatic studies |
Mammalian cell | CSB-MP868328HU | Native folding, Human modifications | Interaction studies, Cell-based assays |
Biotinylated E. coli | CSB-EP868328HU-B | Oriented immobilization | SPR, Pull-down assays |
Selection should be guided by the intended experimental application, with consideration for required protein folding, post-translational modifications, and yield requirements.
When studying PARVA in vascular biology, researchers should consider these cell models:
Human umbilical vein endothelial cells (HUVECs): Well-characterized primary cells for angiogenesis studies
Human aortic smooth muscle cells (HASMCs): Appropriate for studying PARVA in vascular contractility
Immortalized endothelial cell lines (e.g., EA.hy926): Useful for genetic manipulation studies
Co-culture systems combining endothelial and smooth muscle cells: Essential for studying PARVA's role in cell-cell adhesion between these vascular components
3D organotypic cultures: Provide physiologically relevant architecture for studying PARVA in vessel formation
These models can be complemented with appropriate extracellular matrix components to recapitulate specific vascular environments.
Visualizing PARVA in living systems requires specific methodological approaches:
Fluorescent protein fusions (GFP, mCherry) with careful validation of functionality
SNAP or Halo tag systems for flexible labeling options
Fluorescent antibody fragments for endogenous protein tracking
Correlative light-electron microscopy for ultrastructural localization
FRAP (Fluorescence Recovery After Photobleaching) for dynamic mobility assessment
When designing visualization experiments, researchers should control for expression level artifacts and validate that tagged versions retain native functionality through rescue experiments in PARVA-depleted cells.
Multiple quantitative approaches can assess PARVA's functions:
Wound healing assays with automated area measurement
Single-cell tracking for migration speed and directionality
Microfluidic gradient chambers for chemotactic responses
Traction force microscopy to measure cellular force generation
Atomic force microscopy for cell-substrate adhesion strength
FRET-based tension sensors for molecular force transmission
Cell spreading kinetics on various extracellular matrix proteins
Ideally, researchers should combine multiple assays to comprehensively characterize PARVA's role in both migration and adhesion processes, as these cellular functions are mechanistically linked but can be differentially affected.
When manipulating PARVA expression, researchers must consider several methodological factors:
siRNA/shRNA approaches: Provide acute, partial reduction suitable for studying dose-dependent effects and avoiding developmental compensation
CRISPR/Cas9 knockout: Enables complete elimination for studying absolute requirement but may trigger compensatory mechanisms
Inducible systems: Allow temporal control to distinguish developmental versus acute functional requirements
Domain-specific approaches: Can target specific functions while preserving others through truncation or point mutations
Rescue experiments: Essential controls to confirm specificity of observed phenotypes
Careful experimental design should include appropriate controls and validation of knockdown/knockout efficiency at both RNA and protein levels.
Cross-species research on PARVA requires careful reagent selection:
Species | Available Reagents | Cross-Reactivity Considerations |
---|---|---|
Human | Comprehensive antibody panel, Multiple recombinant protein options | Some antibodies cross-react with rodent PARVA |
Mouse | Recombinant proteins from multiple expression systems | Key model for developmental studies |
Rat | Recombinant proteins from multiple expression systems | Useful for cardiovascular physiology studies |
When designing comparative studies, researchers should:
Validate antibody cross-reactivity empirically rather than relying solely on manufacturer claims
Consider sequence homology when interpreting functional conservation
Account for species-specific differences in expression patterns and binding partners
To study PARVA in its native protein complexes:
Optimize cell lysis conditions to preserve interactions (detergent type and concentration)
Consider crosslinking approaches for transient interactions
Implement tandem affinity purification for high-purity complex isolation
Use proximity-dependent biotinylation (BioID, TurboID) to identify interaction neighborhoods
Combine with mass spectrometry for unbiased partner identification
Validate key interactions through reciprocal immunoprecipitation
These approaches should be tailored to the specific cellular context under investigation, as PARVA complexes may vary across cell types and conditions.
Quantitative analysis of PARVA localization requires robust statistical methods:
Pearson's or Mander's correlation coefficients for colocalization analysis
Density-based clustering algorithms for focal adhesion pattern analysis
Bootstrapping approaches for confidence interval estimation in small sample sizes
Mixed-effects models for experiments with multiple cells from multiple experiments
Multivariate analysis for correlating localization with functional outcomes
Machine learning approaches for pattern recognition in complex localization phenotypes
Researchers should clearly report not only statistical significance but also effect sizes to enable proper interpretation of biological relevance.
When facing contradictory findings about PARVA function:
Systematically document cell type-specific differences in PARVA expression level and isoform distribution
Characterize differences in key binding partners across cell types
Consider the influence of extracellular matrix composition and stiffness
Evaluate activation states of upstream signaling pathways
Develop unified models that incorporate cell type as a variable
Implement mathematical modeling to identify parameters that could explain divergent behaviors
This systematic approach can transform apparent contradictions into insights about context-dependent regulation of PARVA function.
Parvin Alpha contains two calponin-homology (CH) domains, which are crucial for its function. These domains allow Parvin Alpha to bind to actin filaments, a key component of the cell’s cytoskeleton . The protein also interacts with integrin-linked protein kinase (ILK) and paxillin, which are involved in cell signaling and adhesion .
The N-terminus of Parvin Alpha has two nuclear localization signals and three potential SH3-binding sites, which are important for its localization and function within the cell . The protein’s structure allows it to play a significant role in the regulation of cell adhesion and cytoskeleton organization .
The PARVA gene is located on chromosome 11p15.3 and contains 13 exons . The gene produces multiple transcripts through the use of different polyadenylation signals. These transcripts encode a protein with a molecular mass of approximately 42.3 kDa .
Parvin Alpha is expressed in most tissues, with the highest expression levels observed in the kidney and heart . It is also expressed throughout mouse embryonic development, indicating its importance in early development .
Recombinant human Parvin Alpha is produced using various expression systems, including E. coli . The recombinant protein is often tagged with GST (Glutathione S-transferase) or His (Histidine) tags to facilitate purification and detection . The recombinant protein is typically lyophilized and can be stored at -20°C to -80°C for long-term stability .
Recombinant Parvin Alpha is used in various research applications, including studies on cell adhesion, cytoskeleton organization, and signal transduction. Its ability to bind actin and interact with other proteins makes it a valuable tool for understanding the molecular mechanisms underlying these processes .